Abstract #4013

Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T

Steffen Goerke¹, Yannick Soehngen¹, Anagha Deshmane², Moritz Zaiss², Johannes Breitling¹, Philip S Boyd¹, Kai Herz², Ferdinand Zimmermann¹, Karel D Klika³, Mark E Ladd¹, and Peter Bachert¹

¹Divsion of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany, ²Department of High-field Magnetic Resonance, Max-Planck-Institute for Biological Cybernetics, Tübingen, Germany, ³Molecular Structure Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany

In this study, the established acquisition protocol for relaxation-compensated APT and rNOE CEST-MRI at 7 T has been successfully transferred to a clinically relevant magnetic field strength of 3 T. This opens up the door to clinical trials with a large number of participants, thus enabling a comprehensive assessment of the clinical relevance of relaxation-compensation in CEST-MRI. The presented CEST sequence is currently part of the clinical routine acquisition protocol for brain tumor patients at our institute.

This abstract and the presentation materials are available to members only; a login is required.

Join Here